Organogenesis (ORGO) News Today $2.89 -0.08 (-2.79%) As of 10:06 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ORGO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Lazard Asset Management LLC Purchases 94,514 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO)Lazard Asset Management LLC raised its position in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 122.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 171,694 shares of the company's stock after purchasinMay 24, 2025 | marketbeat.comSoleus Capital Management L.P. Acquires 645,000 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO)Soleus Capital Management L.P. increased its holdings in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 5.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 12,484,876 shares of the company's stock after acquiMay 21, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Sells 232,865 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO)Jacobs Levy Equity Management Inc. lessened its holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 82.7% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 48,613 shares of the company's stock after selling 2May 21, 2025 | marketbeat.comDeutsche Bank AG Sells 2,393,857 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO)Deutsche Bank AG trimmed its position in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 49.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,449,835 shares of the company's stock after sellingMay 20, 2025 | marketbeat.comDimensional Fund Advisors LP Increases Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO)Dimensional Fund Advisors LP boosted its holdings in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 18.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,789,265 shares of the cMay 12, 2025 | marketbeat.comOrganogenesis Holdings Inc. (ORGO) Q1 2025 Earnings Call TranscriptMay 11, 2025 | seekingalpha.comOrganogenesis Holdings Inc. (NASDAQ:ORGO) Stake Trimmed by AQR Capital Management LLCAQR Capital Management LLC cut its stake in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 43.8% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,522,154 shares of the company's stock after selling 1,188,452 sMay 11, 2025 | marketbeat.comEarnings call transcript: Organogenesis Q1 2025 sees revenue drop, stock plummetsMay 11, 2025 | investing.comEarnings call transcript: Organogenesis Q1 2025 sees revenue drop, stock plummetsMay 11, 2025 | investing.comOrganogenesis Holdings First Quarter 2025 Earnings: Misses ExpectationsMay 10, 2025 | finance.yahoo.comOrganogenesis Holdings Inc. Reports First Quarter 2025 Financial ResultsMay 8, 2025 | globenewswire.comOrganogenesis (ORGO) Projected to Post Quarterly Earnings on ThursdayOrganogenesis (NASDAQ:ORGO) will be releasing its Q1 2025 earnings after the market closes on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-organogenesis-holdings-inc-stock/)May 3, 2025 | marketbeat.comOrganogenesis (NASDAQ:ORGO) Shares Up 3.9% - Here's What HappenedOrganogenesis (NASDAQ:ORGO) Trading 3.9% Higher - Here's WhyMay 1, 2025 | marketbeat.comOrganogenesis Holdings Inc. (NASDAQ:ORGO) Stake Raised by JPMorgan Chase & Co.JPMorgan Chase & Co. raised its position in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 36.4% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 280,997 shares of the company's stock after purchasingApril 30, 2025 | marketbeat.com97,950 Shares in Organogenesis Holdings Inc. (NASDAQ:ORGO) Bought by Jump Financial LLCJump Financial LLC purchased a new stake in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 97,950 shares of the company's stock, valued at approximaApril 29, 2025 | marketbeat.com73,172 Shares in Organogenesis Holdings Inc. (NASDAQ:ORGO) Acquired by XTX Topco LtdXTX Topco Ltd bought a new stake in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 73,172 shares of the company's stock, valued at approximatApril 29, 2025 | marketbeat.comRenaissance Technologies LLC Boosts Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO)Renaissance Technologies LLC increased its position in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 31.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,073,500 shares of the company's stock aftApril 25, 2025 | marketbeat.comOrganogenesis (NASDAQ:ORGO) Trading Down 3.8% - Should You Sell?Organogenesis (NASDAQ:ORGO) Shares Down 3.8% - What's Next?April 16, 2025 | marketbeat.comNorges Bank Purchases Shares of 482,200 Organogenesis Holdings Inc. (NASDAQ:ORGO)Norges Bank purchased a new stake in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 482,200 shares of the company's stock, valued at approximately $1,543,00April 14, 2025 | marketbeat.comCMS reviewing coverage policies for skin substitute productsApril 12, 2025 | markets.businessinsider.comOrganogenesis Supports CMS' Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of EffectivenessApril 11, 2025 | globenewswire.comPrudential Financial Inc. Has $761,000 Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO)Prudential Financial Inc. increased its position in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 92.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 237,720 shares of the company's stockApril 9, 2025 | marketbeat.comOrganogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025April 7, 2025 | globenewswire.comOrganogenesis Highlights Strategic Focus in Investor PresentationMarch 27, 2025 | tipranks.comOrganogenesis (NASDAQ:ORGO) Stock Price Down 5.8% - Should You Sell?Organogenesis (NASDAQ:ORGO) Trading Down 5.8% - Here's WhyMarch 27, 2025 | marketbeat.comOrganogenesis (NASDAQ:ORGO) Shares Gap Up - Should You Buy?Organogenesis (NASDAQ:ORGO) Shares Gap Up - Here's What HappenedMarch 26, 2025 | marketbeat.comOrganogenesis (NASDAQ:ORGO) Stock Price Up 9.5% - Time to Buy?Organogenesis (NASDAQ:ORGO) Stock Price Up 9.5% - Here's What HappenedMarch 25, 2025 | marketbeat.comOrganogenesis Holdings Inc. (NASDAQ:ORGO) Stock Position Raised by Bank of New York Mellon CorpBank of New York Mellon Corp grew its position in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 35.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 418,820 shares of the company's stock after purchasinMarch 24, 2025 | marketbeat.comOrganogenesis (NASDAQ:ORGO) Trading Up 3.5% - What's Next?Organogenesis (NASDAQ:ORGO) Trading Up 3.5% - Still a Buy?March 19, 2025 | marketbeat.comOrganogenesis Holdings: Solid Finances Protect From Uncertain EnvironmentMarch 18, 2025 | seekingalpha.comOrganogenesis (NASDAQ:ORGO) Trading Down 2.1% - What's Next?Organogenesis (NASDAQ:ORGO) Stock Price Down 2.1% - What's Next?March 15, 2025 | marketbeat.comOrganogenesis Holdings Inc. (NASDAQ:ORGO) Director Sells $127,500.00 in StockOrganogenesis Holdings Inc. (NASDAQ:ORGO - Get Free Report) Director Michael Joseph Driscoll sold 25,000 shares of the company's stock in a transaction dated Tuesday, March 4th. The stock was sold at an average price of $5.10, for a total transaction of $127,500.00. Following the sale, the director now directly owns 166,879 shares of the company's stock, valued at $851,082.90. This represents a 13.03 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.March 7, 2025 | marketbeat.comInsider Selling: Organogenesis Holdings Inc. (NASDAQ:ORGO) Director Sells 25,000 Shares of StockMarch 7, 2025 | insidertrades.comOrganogenesis (NASDAQ:ORGO) Stock Price Up 9.1% After Analyst UpgradeOrganogenesis (NASDAQ:ORGO) Trading 9.1% Higher After Analyst UpgradeMarch 6, 2025 | marketbeat.comOrganogenesis (NASDAQ:ORGO) Price Target Raised to $6.00Morgan Stanley increased their price target on Organogenesis from $4.00 to $6.00 and gave the company an "equal weight" rating in a research note on Wednesday.March 6, 2025 | marketbeat.comOrganogenesis (NASDAQ:ORGO) Stock Price Down 6.2% - Here's What HappenedOrganogenesis (NASDAQ:ORGO) Shares Down 6.2% - Time to Sell?March 5, 2025 | marketbeat.comMorgan Stanley Keeps Their Hold Rating on Organogenesis Holdings (ORGO)March 5, 2025 | markets.businessinsider.comOrganogenesis price target raised to $6 from $4 at Morgan StanleyMarch 5, 2025 | markets.businessinsider.comBTIG Sticks to Its Buy Rating for Organogenesis Holdings (ORGO)March 5, 2025 | markets.businessinsider.comCornerstone Investment Partners LLC Buys Shares of 50,502 Organogenesis Holdings Inc. (NASDAQ:ORGO)Cornerstone Investment Partners LLC purchased a new position in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 50,502 shares of the company's stock,March 5, 2025 | marketbeat.comOrganogenesis (NASDAQ:ORGO) Shares Gap Down - Here's WhyOrganogenesis (NASDAQ:ORGO) Shares Gap Down - Time to Sell?March 3, 2025 | marketbeat.comOrganogenesis (NASDAQ:ORGO) Sets New 12-Month High - Should You Buy?Organogenesis (NASDAQ:ORGO) Hits New 1-Year High - Time to Buy?March 1, 2025 | marketbeat.comOrganogenesis Hldgs (NASDAQ:ORGO) Stock Quotes, Forecast and News SummaryMarch 1, 2025 | benzinga.comOrganogenesis (NASDAQ:ORGO) Issues Earnings ResultsOrganogenesis (NASDAQ:ORGO - Get Free Report) announced its quarterly earnings data on Thursday. The company reported $0.04 earnings per share for the quarter, beating the consensus estimate of ($0.03) by $0.07. Organogenesis had a negative return on equity of 2.69% and a negative net margin of 1.62%.February 28, 2025 | marketbeat.comOrganogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2024 Earnings Call TranscriptFebruary 28, 2025 | insidermonkey.comOrganogenesis price target raised to $7 from $6 at BTIGFebruary 28, 2025 | markets.businessinsider.comLake Street Remains a Buy on Organogenesis Holdings (ORGO)February 28, 2025 | markets.businessinsider.comOrganogenesis (ORGO) Q4 2024 Earnings Call TranscriptFebruary 28, 2025 | msn.comOrganogenesis Holdings Inc. (ORGO) Q4 2024 Earnings Call TranscriptFebruary 27, 2025 | seekingalpha.comOrganogenesis stock surges on earnings beat, strong guidanceFebruary 27, 2025 | in.investing.com Get Organogenesis News Delivered to You Automatically Sign up to receive the latest news and ratings for ORGO and its competitors with MarketBeat's FREE daily newsletter. Email Address ORGO Media Mentions By Week ORGO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ORGO News Sentiment▼1.781.03▲Average Medical News Sentiment ORGO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ORGO Articles This Week▼42▲ORGO Articles Average Week Get Organogenesis News Delivered to You Automatically Sign up to receive the latest news and ratings for ORGO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ARS Pharmaceuticals News Qilian International Holding Group News Structure Therapeutics News Travere Therapeutics News Mesoblast News 89bio News Adaptive Biotechnologies News Dyne Therapeutics News Vera Therapeutics News ANI Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ORGO) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredDollar Collapse Warning: Protect Your Wealth NOWGlobal central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...Lear Capital | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organogenesis Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organogenesis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
